https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-07-18 / Cancer Immunol. Immunother. 2010 Jan;59(1):1-11
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-07-18 / Cancer Immunol. Immunother. 2010 Jan;59(1):1-112009-07-18 00:00:002019-02-15 08:44:12Killer dendritic cells and their potential for cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-07-08 / Cochrane Database Syst Rev 2009 Jul;(3):CD006269
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-07-08 / Cochrane Database Syst Rev 2009 Jul;(3):CD0062692009-07-08 00:00:002019-02-15 08:38:00Concomitant hyperthermia and radiation therapy for treating locally advanced rectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-07-07 / Clin. Cancer Res. 2009 Jul;15(14):4612-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-07-07 / Clin. Cancer Res. 2009 Jul;15(14):4612-212009-07-07 00:00:002019-02-15 08:44:17Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-07-01 / J. Intern. Med. 2009 Jul;266(1):99-113
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-07-01 / J. Intern. Med. 2009 Jul;266(1):99-1132009-07-01 00:00:002019-02-15 08:53:36Beyond RET: potential therapeutic approaches for advanced and metastatic medullary thyroid carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2009-07-01 / J. Immunother. 2009 Jul-Aug;32(6):638-54
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2009-07-01 / J. Immunother. 2009 Jul-Aug;32(6):638-542009-07-01 00:00:002019-02-15 08:44:18Cryopreservation of monocytes is superior to cryopreservation of immature or semi-mature dendritic cells for dendritic cell-based immunotherapy
